Generation of biological association networks: A novel strategy to detect new targets in cancer therapy


Autoria(s): Selga i Coma, Elisabet; Almagro García, Ma. Cristina de; Oleaga, Carlota; Mencial, Núria; Ramírez, Sara; Ruiz, F. Xavier; Farrés i Vicén, Jaume; Parés i Casasampera, Xavier; Thibaut, Rémi; Porte Visa, Cinta; Noé Mata, Verónica; Ciudad i Gómez, Carlos Julián
Contribuinte(s)

Universitat de Barcelona

Data(s)

27/01/2012

Resumo

The aim of this work was to design a novel strategy to detect new targets for anticancer treatments. The rationale was to build Biological Association Networks from differentially expressed genes in drug-resistant cells to identify important nodes within the Networks. These nodes may represent putative targets to attack in cancer therapy, as a way to destabilize the gene network developed by the resistant cells to escape from the drug pressure. As a model we used cells resistant to methotrexate (MTX), an inhibitor of DHFR. Selected node-genes were analyzed at the transcriptional level and from a genotypic point of view. In colon cancer cells, DHFR, the AKR1 family, PKC¿, S100A4, DKK1, and CAV1 were overexpressed while E-cadherin was lost. In breast cancer cells, the UGT1A family was overexpressed, whereas EEF1A1 was overexpressed in pancreatic cells. Interference RNAs directed against these targets sensitized cells towards MTX.

Podeu consultar el llibre complet a: http://www.trnres.com/ebookcontents.php?id=149

Identificador

http://hdl.handle.net/2445/21368

Idioma(s)

eng

Publicador

Transworld Research Network

Direitos

(c) Transworld Research Network, 2011

info:eu-repo/semantics/openAccess

<a href="http://hdl.handle.net/2445/32392">http://hdl.handle.net/2445/32392</a>

Palavras-Chave #Càncer #Quimioteràpia #Farmacogenètica #Cancer #Chemotherapy #Pharmacogenetics
Tipo

info:eu-repo/semantics/bookPart